N- NABLA 3 deletion mutants of the short form of CSF-1

New forms of CSF-1 are provided which relate to N-terminal truncations. Specifically, N- NABLA 3 terminal truncations of the short form of CSF-1 have been found to be particularly advantageous. These forms may have a C-terminal truncation at a variety of different amino acids beyond position 150.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	LADNER, MARTHA B, COYNE, MAZIE Y, HALENBECK, ROBERT F, MARTIN, GEORGE A, KAWASAKI, ERNEST S, NOBLE, JANELLE A, KOTHS, KIRSTON E
Format:	Patent
Sprache:	eng
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	New forms of CSF-1 are provided which relate to N-terminal truncations. Specifically, N- NABLA 3 terminal truncations of the short form of CSF-1 have been found to be particularly advantageous. These forms may have a C-terminal truncation at a variety of different amino acids beyond position 150.